ABT vs GIS · P/E 25, rev $44.33B vs P/E 8.2, rev $18.42B
Abbott Laboratories (ABT) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the ABT and GIS stock pages for the full models.
Not investment advice.